Bellberry CEO Kylie Sproston said, “We are delighted that Dr Simon Foster is the Bellberry-Viertel Fellow for 2023, and becomes the fifth Bellberry-Viertel Fellow selected through our ongoing collaboration with the Viertel Foundation and Equity Trustees.”
New research grants will help reduce infectious diseases and heart disease
November 2, 2023 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Pilot study confirms adjunct NB-UVB needed to activate repigmentation in vitiligo
June 18, 2025 - - Australian Biotech -
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News -
Canadian appointed to lead New Zealand's Pharmac
June 17, 2025 - - Latest News -
US FDA approves CSL's treatment for hereditary angioedema
June 17, 2025 - - Latest News -
Australia's system is more uniform than the US, but not uniformly better
June 17, 2025 - - Latest News -
Australian company secures FDA approval to progress development of CAR-T therapy
June 16, 2025 - - Latest News -
These systems are and always have been more similar than most realise
June 16, 2025 - - Latest News